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ACHILLES TENDON INJURY: INCIDENCE, ETIOLOGIES, TREATMENTS, 
AND OUTCOMES 
 
GRIFFIN A. BLEECKER 
ABSTRACT 
 The Achilles tendon is the largest single tendon in the body and critical for 
common movements. Achilles tendon injuries are common, with rising levels of 
incidence in the western world. Current trends indicate that levels of Achilles tendon 
injuries will continue to rise globally. These are also impactful injuries, often resulting in 
long term alterations in lives and activities. Particularly devastating are the effects of 
Achilles tendon injury on athletes. The goal of this thesis is to contextualize these injuries 
and trends, providing a system of categorization for understanding and classifying 
Achilles tendon injuries. The normal structure and function of the Achilles tendon is 
introduced, followed by a discussion of a series of factors that can lead to Achilles tendon 
injury. Achilles tendon injuries are sorted into a clinically relevant framework and the 
various treatments and outcomes for these injuries are explored, with an eye towards 
potential areas of further research. Taken together, these analyses show the importance 
and prevalence of Achilles tendon injuries, some of the inherent challenges in dealing 
with these injuries, and also demonstrate the necessity for further study and exploration 
of Achilles tendon injuries.   
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 1 
INTRODUCTION 
 
 The Achilles tendon, also known as the calcaneal tendon and referred to 
interchangeably as such henceforth, is critical for a variety of motions and actions. The 
thickest and strongest tendon in the body, the Achilles tendon serves as the insertion of 
the gastrocnemius, soleus, and plantaris muscles of the posterior lower leg into the 
middle portion of the calcaneus (Figure 1) (Drake et al., 2012). The gastrocnemius and 
soleus muscles together make up the triceps surae transferring force through the calcaneal 
tendon across the ankle joint and serving to plantar flex the foot, invert the hindfoot, as 
well as flexing the knee, while the plantaris also works through the calcaneal tendon to 
plantar flex the foot and invert the hindfoot (Drake et al., 2012). 
       
 
 
 
Figure 1: Musculature and Insertion of 
the Calcaneal Tendon The Achilles tendon 
is shown in the posterior portion of the lower 
leg serving as the insertion of the triceps 
surae (the two heads of the gastrocnemius 
and the soleus muscles) as well as the 
plantaris muscle into the calcaneus. Adapted 
from wikicomons OpenStax Anatomy and 
Physiology (OpenStax, 2016) 
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The calcaneal tendon serves to transmit the force generated by the contraction of 
these muscles, particularly the triceps surae, across the ankle joint. In this capacity the 
Achilles tendon plays an important role in stabilizing the tibia during standing (Saini et 
al., 2015). 
During locomotion, the Achilles tendon acts in two capacities to aid in propulsion 
for walking, running, and jumping (Saini et al., 2015). During the stance phase of gait, 
the triceps surae eccentrically contracts in order to control the forward progression of the 
tibia through the calcaneal tendon. Beginning in the terminal stance phase and continuing 
through the toe-off phase of gait, the triceps surae concentrically contracts against the 
fixed forefoot passing the energy necessary for ambulation through the calcaneal tendon 
(Saini et al., 2015). The diversity of these functions, coupled with their ubiquity in 
common actions, means that the Achilles tendon serves an important role in day-to-day 
life, not just in high functioning activities or athletics. Shortly put, Achilles tendon injury 
can be devastating. 
 Frank rupture of the Achilles tendon, first described by the French barber surgeon 
Ambrose Paré in 1575 (Paré, 1633), is obviously the most severe of the myriad Achilles 
tendon injuries that occur, but other injuries including partial rupture, strain, 
inflammation, and swelling can still be painful, restrictive, and debilitating. It is 
important to have an understanding of the structural makeup and the function of the 
Achilles tendon in order to fully appreciate a discussion of these various injuries.  
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Achilles Tendon Structure 
In order to continue with a discussion of the disparate factors that contribute to 
Achilles tendon injuries, and their outcomes it is important to have a working 
understanding of not only the general anatomy and function of the calcaneal tendon at a 
macroscopic level, but also at a microscopic level. The cellular makeup, activity, and 
functioning of the numerous cells in the Achilles tendon are important determinants of 
severity and likelihood of injuries, and therefore it is necessary to understand their 
distribution in a healthy Achilles tendon. 
Like most other tendons in the body, the Achilles tendon is composed primarily of 
sparsely dispersed cells spread throughout a network of extracellular matrix proteins and 
ground substances (Sharma and Maffulli, 2005). In the Achilles tendon, the materials that 
make up this extracellular matrix include collagen and elastin, while the ground 
substance is composed of glycosaminoglycans, glycoproteins, and proteoglycans. Of 
these extracellular components, the most substantial, in both quantity and structural 
importance, is collagen (Li and Hua, 2016; Sharma and Maffulli, 2005). 
Collagen 
 Collagen accounts for more than 90% of the protein found in the Achilles tendon 
(Li and Hua, 2016; Sharma and Maffulli, 2005). This collagen is also responsible for 70-
80% of the dry weight of the entire calcaneal tendon (Li and Hua, 2016; Sharma and 
Maffulli, 2005). The dry mass of the tendon is approximately one third of the weight of 
the in vivo tendon, and represents a measurement of an Achilles tendon that has been 
dehydrated in order to facilitate the study of the non-water structural components of the 
tissue (Sharma and Maffulli, 2005). 
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The collagen of the Achilles tendon is almost entirely type I collagen, but includes 
several other types of collagen (Li and Hua, 2016). Type I collagen makes up 95% of the 
collagen present in the calcaneal tendon and is the primary structural component of the 
tendon, and the majority of the type I collagen is organized longitudinally, in parallel 
with the axis of the tendon (Li and Hua, 2016).  
Type III collagen is also found in the Achilles tendon, plays an important role in 
both development and healing of the tendon (Li and Hua, 2016). The type III fibers are 
smaller and less organized than the type I fibers in the Achilles tendon, and consequently 
an overabundance of these fibers can result in mechanical weaknesses in the tendon (Li 
and Hua, 2016).  
Type V and type XII collagen fibers can also be found in the Achilles tendon (Li 
and Hua, 2016). Type V fibers are found intercalated into the core of type I collagen 
fibrils where they help to regulate the growth of the fibrils, as well as serving as frames 
for fibrillogenesis (Kirkendall and Garrett, 1997). The role of type XII collagen in 
tendons has not been definitively determined, but given the highly “sticky” nature of the 
fibers, binding to proteoglycans and other ground substance components, it has been 
posited that type XII serves an integrating function, joining other extracellular 
components (Li and Hua, 2016). 
These collagen components, secreted as soluble tropocollagen molecules, come 
together to form a patterned structure (Sharma and Maffulli, 2005). These soluble 
tropocollagen molecules are the 14 Å wide and 2800 Å long fundamental units of 
collagen secreted by the fibroblast like tenoblasts and tenocyte cells of the tendon 
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(“Connective Tissue,” n.d.). These tropocollagen molecules cross link to each other, 
becoming insoluble, and then aggregate into collagen fibrils, which form the finest 
component of the hierarchical structure of the tendon (Sharma and Maffulli, 2005). 
Type I collagen fibrils are arranged longitudinally, parallel to the direction of the 
tendon axis, and impose the pattern of protein deposition that gives the tendon its tensile 
strength (Sharma and Maffulli, 2005). Collections of these wire like fibrils form cable 
like fibers, the next largest subunit of tendon structure. Fibers in turn are grouped into 
primary bundles, also known as subfasicles, surrounded by a layer of endotenon. These 
subfasicles are grouped into secondary fiber bundles, also known as fascicles, which are 
encapsulated by another layer of endotenon. The fascicles come together to form tertiary 
fiber bundles, also surrounded by endotenon. The tertiary bundles are the largest subunit 
of the tendon, and, when joined together in a sheath of epitenon, form the tendon. On the 
exterior of this outermost layer of epitenon is the paratenon, the layer that surrounds the 
Achilles tendon and serves as the tendon sheath, compartmentalizing the tendon from the 
rest of the body (Figure 2) (Sharma and Maffulli, 2005; sportEX journals, 2010). 
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Figure 2: Type I Collagen Hierarchy in Tendons The Grouping of type I 
collagen molecules can be seen. Collagen fibrils made up of cross-linked tropocollagen 
molecules form the smallest unit. These fibrils come together to form collagen fibers. The 
collagen fibers form subfascicles, which in turn form fascicles, and then tertiary fiber 
bundles; each subdivision is encapsulated in an endotenon sheath. The tertiary fiber 
bundles coalesce to form the tendon, surrounded by a layer of epitenon, which is in turn 
sheathed in the paratenon (Sharma and Maffulli, 2005). Image taken from (sportEX 
journals, 2010). 
  
This highly organized network of collagenous molecules provides the majority of 
the structure of the Achilles tendon, as well as much of the tensile strength of the tendon 
(Sharma and Maffulli, 2005). The mostly longitudinal arrangement of type I collagen 
fibrils, fibers, etc. allows for the transmission of force along the length of the tendon from 
the muscles of the posterior lower leg across, the ankle joint, and into the calcaneus 
(Sharma and Maffulli, 2005). 
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Elastin and Other Extracellular Components  
Interwoven throughout this network of collagen fibers is the second most 
abundant extracellular matrix protein, elastin (Sharma and Maffulli, 2005). Elastin in the 
Achilles tendon provides the small degree of elasticity and the resilience that is necessary 
for the proper functioning of the tendon. Elastin makes up around two percent of the dry 
mass of the tendon, which although far less than the around 90% attributed to collagen, 
makes elastin the second most abundant extracellular matrix protein in the Achilles 
tendon (Ippolito et al., 1980).  
This elastin component of the Achilles tendon is critical for providing the 
flexibility and extensibility of the tissue (Kirkendall and Garrett, 1997). These properties 
are very important in the biomechanical functioning of the Achilles tendon, allowing for 
the tendon to bend around the ankle joint and to serve as a shock absorber and energy 
recycler, muffling impacts and storing elastic potential energy throughout various phases 
of gait (Kirkendall and Garrett, 1997).    
These extracellular proteins, elastin and collagen of varying types, are the main 
components of the relatively acellular tissue that makes up the Achilles tendon, giving the 
tendon its major characteristics, but are not the only extracellular substances present. A 
significant amount of ground substance also contributes to the make-up of the tendon. 
This ground substance is principally composed of glycosaminoglycan, glycoproteins, 
proteoglycans (Sharma and Maffulli, 2005). These substances fill in the space of the 
tendon, covering the framework defined by the extracellular proteins collagen and elastin 
while providing the hydration needed to perfuse the healthy tendon, as well as adding to 
the overall elasticity of the tendon with their hydrophilicity (Sharma and Maffulli, 2005). 
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Cellular Components of the Achilles Tendon 
Also of critical importance to the natural appearance, character, and function of 
the Achilles tendon are the cells found in the tissue. Spread throughout the Achilles 
tendon, in differing concentrations at differing locations, and usually tucked within the 
type I collagen network that provides the structure of the Achilles tendon are a variety of 
cell types (Sharma and Maffulli, 2005). These cell types include tenocytes, tenoblasts, 
synovial cells, smooth muscle cells, and chondrocytes. Of these cells types, the most 
abundant and most influential are the tenocytes and tenoblasts making up 90-95% of the 
cells of the tendon and found dispersed throughout the tissue (Sharma and Maffulli, 
2005).  
The remaining cell types are found in the areas that one would expect, with 
chondrocytes and smooth muscle cells located at the entheses where the tendon joins 
other tissue types, and synovial cells and vascular cells near to and in the synovial 
vascularized sheathe surrounding the tendon (Kader et al., 2002; Sharma and Maffulli, 
2005).   
Of these cells, tenocytes and tenoblasts are not only the most significant 
numerically, but also functionally. Tenocytes and tenoblasts, the tendon homologues to 
fibrocytes and fibroblasts, are distributed throughout the Achilles tendon, and are 
responsible for the upkeep, synthesis, and regulation of the various substances of the 
extracellular matrix (Ribbans and Collins, 2013). These cells produce the collagen, 
elastin, and other extracellular substances that give the Achilles tendon its biologically 
relevant properties, and are essential to the maintenance of a functioning Achilles tendon 
(“Tendon,” n.d.).  
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In the majority of tissue in a healthy tendon, excluding some peripheral regions 
near the ends and exterior of the tendon, the only cells present are tenocytes and 
tenoblasts (Ribbans and Collins, 2013). Tenocytes are the mature cells, fusiform in 
appearance and analogous to fibroblasts, whose effective action is conditional upon 
interaction with collagen fibers, and are therefore found anchored to collagen fibers 
(Ribbans and Collins, 2013; “Tendon,” n.d.). Mature tenocytes also express actin and 
mysosin, allowing them to directly contribute to the mechanical properties of the tendon 
while attached to the collagen fibers (Ippolito et al., 1980).  
Tenoblasts, in contrast, are immature cells, analogous to fibrocytes and spindle 
shaped, that are found in bundles clustered together not associated with collagen fibers 
(Ribbans and Collins, 2013). Tenoblasts are highly proliferative and mature into 
tenocytes (“Tendon,” n.d.).  
It is unclear where in this process of maturation synthesis of the extracellular 
matrix substances occurs, specifically in tenocytes or tenoblasts, but both cell types are 
involved in the signaling and regulation of this synthesis process, regardless of which cell 
(if it is only one of the two) is directly responsible for synthesis (Ribbans and Collins, 
2013; “Tendon,” n.d.). 
Vascularization, Innervation, and Lymphatic Inclusion                
The calcaneal tendon is not surrounded by a true layer of synovial sheath like the 
one that is present on other tendons, but is instead enshrouded only in a covering of 
paretenon (Saini et al., 2015; Weinfeld, 2014). This paretenon is formed by a single layer 
of fatty cells highly vascularized by branches of the posterior tibial and the peroneal 
arteries. This paratenon covering is responsible for the majority of the perfusion of the 
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calcaneal tendon, and the tendon tissue itself is mostly avascular (Saini et al., 2015; 
Weinfeld, 2014).  
Blood supply when present, lymphatic drainage, and innervation to the tissue of 
the Achilles tendon is provided through the epitenon (Sharma and Maffulli, 2005). The 
epitenon is a loose layer of connective tissues that contains vessels and nerves, surrounds 
the tendon, and dives in between tertiary fiber bundles to access, innervate, and perfuse 
the tissue of the tendon (Figure 2) (Sharma and Maffulli, 2005; sportEX journals, 2010). 
This atypical encapsulation and vascularization of the Achilles tendon results in 
an atypical pattern of perfusion. The vast majority of blood flow into the calcaneal tendon 
occurs from the anterior side at the insertional or original ends of the tendon, with a large 
poorly perfused section in the middle of the tendon (Asplund and Best, 2013; Saini et al., 
2015; Weinfeld, 2014). This region, spanning from two to six centimeters above the 
insertion of the tendon into the calcaneus, is markedly at risk of hypovascular incident, 
and consequently is highly susceptible to injury in times of damage or stress (Asplund 
and Best, 2013; Saini et al., 2015; Weinfeld, 2014). It is also a region characterized by 
noticeably poor healing. The poor blood flow to this middle portion of the calcaneal 
tendon leaves it susceptible to rupture and predisposed to chronic inflammation, an 
occurrence that exaggerates the region’s already poor ability to heal and exacerbates the 
region’s risk of rupture (Asplund and Best, 2013; Saini et al., 2015; Weinfeld, 2014).  
 
Biomechanics 
The proportionality of collagen, elastin, and other extracellular components of the 
Achilles tendon is crucial to the performance of the tendon in its main functions 
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transducing and storing forces from muscles to bone (Sharma and Maffulli, 2005). In 
order to preserve this force, the tendon needs to be strong and fibrous, undergoing very 
little elastic deformation which would represent a loss of force. Some flexibility is 
absolutely critical, however, allowing the Achilles tendon to move with the body and the 
muscles and bones it is attached to and blunting potential shearing forces that could 
damage the tendon.  
This flexibility is also critically important to help the tendon serve as a shock 
absorber. In addition to transmitting force generated by the gastrocnemius, soleus, and 
plantaris muscles, the Achilles tendon is an important tissue for dissipating external 
forces that enter the body through the lower leg, including the shocks of walking and 
running felt on the heel (Sharma and Maffulli, 2005).  
The biomechanical properties of the Achilles tendon are well suited to dealing 
with these challenges, and are a result of the microscopic organization and composition 
of the tissue. Elastin is highly stretchable, undergoing up to 200% mechanical strain 
across a fiber before experiencing failure (Ippolito et al., 1980). This means that the 
relative paucity of elastic fibers found in the Achilles tendon (roughly 2% of the dry 
weight of the tendon) is just enough to insure the correct amount of elasticity in the 
tendon (Ippolito et al., 1980). It is the presence of these elastin fibers that gives the 
Achilles tendon its recognizable viscoelastic properties, allowing it to be both strong and 
flexible, serving several biomechanical functions (Sharma and Maffulli, 2005). 
 Like other viscoelastic substances, tendons undergo stress relaxation and creep, 
properties with interesting biomechanical implications (Figure 3). Stress relaxation is a 
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property of tendons that is a direct result of their elasticity (Sharma and Maffulli, 2005). 
When tendons are deformed a certain amount and held in that deformed position, the 
stress felt across the tendon relaxes, or decreases with time (University of Texas at 
Austin, n.d.). This stress relaxation, decreasing forces with constant deformation, is an 
intuitive result of the elastic nature of tendons and helps provide the flexibility crucial to 
tendon function (University of Texas at Austin, n.d.). As the tendon remains deformed, 
the fibers themselves stretch, releasing some of the force required to deform the tendon, 
easing stress on across the tendon (University of Texas at Austin, n.d.).  
The other viscoelastic property demonstrated by the Achilles tendon, creep, is not 
as clearly a result of the elastin fibers found in the tendon, but still important to tendon 
function. Creep is the name given to the phenomenon of increasing deformity under 
constant stress (University of Texas at Austin, n.d.). When a force is applied to a material 
there is a certain amount of deformation to counteract that force before a stable position 
is reached, but if the force remains constant in a material that undergoes creep, like a 
tendon, the deformation continues to grow in a relatively proportional manner (University 
of Texas at Austin, n.d.). Less technically and more understandably, if a tendon is loaded 
it will undergo some stretching before the force across the tendon is relieved, however if 
that force remains constant, the tendon will continue to deform (creep), possibly tearing 
(University of Texas at Austin, n.d.).  
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Figure 3 Stress Relaxation 
and Creep Stress and Strain: 
Stress and strain curves of a 
material undergoing stress 
relaxation and creep. In the 
Achilles tendon stress represents 
force across the tendon while strain 
represents deformation (stretching) 
of the tendon. A Stress Relaxation 
As can be seen from the top curve, 
a constant strain (deformation) is 
applied to the tendon and the initial 
stress (force) dissipates over time, 
as observed on the bottom curve. B 
Creep As can be seen on the 
bottom curve, a constant stress 
(force) is applied to the tendon and 
the initial stain (deformation) seen 
grows, as demonstrated on the 
bottom curve (University of Texas 
at Austin, n.d.). Image taken from 
(Faffe and Zin, 2009). 
 
 
Both stress relaxation and creep are properties of the Achilles tendon that are 
crucial to its function, and possible biomechanical explanations for some of the patterns 
of injury observed (Ippolito et al. 1980). These are both also properties characteristic of a 
viscoelastic tissue and this viscoelasticity is imparted on the Achilles tendon by the 
elastin fibers that run through it, suggesting that those fibers are central to the proper 
functioning of the calcaneal tendon (Ippolito et al., 1980).  
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In fact, non-human histological studies have suggested that as the Achilles tendon 
ages, the amount of elastin fibers found in the tendon drops, and the quality of those 
fibers also degrades with age (Ippolito et al., 1980). This decline in quantity and quality 
of elastin fibers observed in the calcaneal tendon over time suggests one possible 
explanation for the degradation of Achilles tendon injury resistance with age, a 
phenomenon discussed in the body of this work. As these crucial elastin fibers diminish 
with age, so too does the functionality of the Achilles tendon (Ippolito et al., 1980). 
In summary, the Achilles tendon is a structure with very specific properties that 
allow it to function in the body. These properties are a result of properties the 
microscopic components of the Achilles tendon including collagen and elastin. These 
components themselves are arranged in a highly organized pattern that gives rise to the 
shape and appearance of the Achilles tendon. All of these characteristics contribute to the 
functionality of the Achilles tendon as it acts across the ankle joint, serving to transmit 
and absorb forces throughout normal gait. 
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DISCUSSION 
 The Achilles tendon is an important and complex structure whose various 
functions and components were presented in the introduction of this thesis. A healthy 
Achilles tendon was detailed in that portion of this work to provide a comparison and a 
launching point for this discussion. In this section of this thesis a series of disruptions and 
disturbances that alter the structure, quantity, and quality of the microscopic components 
of the Achilles tendon will be discussed. The implications of each of these on Achilles 
tendon health will be touched upon, followed by an introduction of the clinically 
significant categorization of Achilles tendon injuries, their incidence, various treatment 
strategies, and outcomes of these treatments.      
 
Etiologies 
Regulation of tenocytes and tenoblasts, as well as their associated maturating, 
organizing, and synthesizing processes governing the extracellular matrix of the Achilles 
tendon is under the control of complex and not fully explored web of mechanisms 
involving a variety of molecules. A series of these factors, their effects, and pathologies 
resulting from their dysregulation are presented below. 
Tenascin C   
One of the most influential and well understood of these molecules controlling the 
cellular makeup of the Achilles tendon is tenascin C. Tenascin C is a hexameric 
glycoprotein that aids in the interaction of tenocytes and the extracellular matrix (Ribbans 
and Collins, 2013). A product of the TNC gene, tenascin C is made up of several different 
structural elements that can bind to cell surface receptors expressed by tenocytes as well 
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as to components of the extracellular matrix, which allows tenascin C to serve its 
function as a link between the extracellular and cellular elements of the tendon (Ribbans 
and Collins, 2013). Tenascin C itself exists in the extracellular space of the tendon, and is 
an elastin like protein that can be stretched to several times its resting length before 
returning to its original size (Ribbans and Collins, 2013). This property is a result of the 
unfolding of fibronectin type domains within the tenascin C molecule, and means that 
Tenascin C helps to provide some of the elasticity central to the functioning of the 
Achilles tendon (Järvinen et al., 2000). 
 Expression of TNC, leading to the presence of tenascin C in the tendon, is, to 
some degree, related to the load across the tendon as indicated by the fact that increasing 
load is associated with increased Tenascin C (Ribbans and Collins, 2013). This is, to a 
certain extent, a protective function, however an overexpression of tenascin C is 
associated with a pathologic Achilles tendon (Ribbans and Collins, 2013). In fact, an 
entirely different isoform of tenascin C is also linked with diseased Achilles tendons, 
further indicating that dysregulation of this molecule can have serious consequences on 
Achilles tendon health (Ribbans and Collins, 2013).  
Further evidence that dysregulation or malfunction of this TNC gene, leading to 
alterations in the expression and action of tenascin C, was found in an examination of 
South Africans suffering Achilles tendon injuries. Looking at a large cohort of subjects 
with Achilles tendon injuries and another group of activity and race matched healthy 
individuals serving as the control, those patients with injuries were significantly (p=.001) 
 17 
more likely to have one of several dysregulating or function altering polymorphisms in 
the TNC gene (Mokone et al., 2005).  
Looking at the study population as a whole, it was determined that subjects with 
one of two specific TNC polymorphisms had a six fold higher chance of suffering an 
Achilles tendon injury than their non-polymorphic counterparts (Mokone et al., 2005).  
Matrix Metalloproteases and Matrix Metalloprotease Tissue Inhibitors 
Another example of defects in the expression or regulation of a crucial tenocyte 
signaling molecule leading to increased risk of Achilles tendon injury is seen in the 
classes of molecules called matrix metalloproteases and their tissue inhibitors. These 
tissue inhibitors of matrix metalloproteases (TIMP) and the matrix metalloproteases 
(MMP) themselves are both normally present in healthy Achilles tendon tissues, existing 
in an equilibrium and counterbalancing each other’s effects (Ribbans and Collins, 2013). 
Matrix metalloproteases degrade the proteins of the extracellular matrix, particularly 
collagen, while TIMPs prevent them from serving this function (Ribbans and Collins, 
2013). There is a certain amount of remodeling that goes on continuously in a healthy 
Achilles tendon, and the homeostatic remodeling of the extracellular matrix is a carefully 
balanced process. Impairment of this process, due to endogenous, genetic, or exogenous 
factors can result in an overexpression of MMPs, with respect to the TIMPs of those 
proteases, leading to a degraded and more injury prone Achilles tendon (Ribbans and 
Collins, 2013).  
One established exogenous factor that interferes with this equilibrium is the use of 
fluoroquinolone antibiotics. Fluoroquinolone antibiotics, like ciprofloxacin, norfloxacin, 
and ofloxacin, have long been suspected to increase the risk of tendon injury, and it is 
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through their interference upon the balance of matrix metalloproteases and tissue 
inhibitors that this effect is caused (Corps et al., 2005). There are many types of TIMPS 
and MMPs, and the effect of fluoroquinolone antibiotics on each of them differs in 
magnitude and direction, upregulating some metalloproteases while simultaneously 
downregulating others (Corps et al., 2005).  
The complex interactions between each of the various MMPs and each of the 
TIMPs form a sophisticated network of communication, and the effects of 
fluoroquinolone exposure on each component of this system is beyond the scope of this 
work, however the general trend is clear. Upon treatment with fluoroquinolone antibiotics 
a notable degradation of type I collagen is observed in the tissue of Achilles tendons, 
leading to weaker and more injury prone tendons (Tsai et al., 2011). This degradation is 
the result of a net imbalance of metalloproteases and tissue inhibitors leading to a net 
increase in MMP action in studied tissue over non-fluoroquinolone exposed tissue (Corps 
et al., 2005). 
Looking beyond fluoroquinolone exposure and other exogenous factors, there are 
also a number of endogenous factors that can interfere with the normal homeostatic 
relationship of metalloproteases and their tissue inhibitors. Genetic alterations, of course, 
can have significant effects on the functionality of both metalloproteases and tissue 
inhibitors leading to dysregulation and an increased chance of injury, but there is also 
some indication that epigenetics can impact this system (Jones et al., 2006).  
The MMP-23 is the locus for many of the matrix metalloproteases relevant to 
Achilles tendon tissues, and has a CpG island methylation site in its promoter region 
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(Jones et al., 2006). Studies have shown a distinct expression pattern of this gene in 
patients with chronically injured or painful Achilles tendons, suggesting a difference in 
epigenetic activity of this gene (Jones et al., 2006). This matrix metalloprotease and 
tissue inhibitor system provides an important regulatory system for the activity and 
function of the Achilles tendon on the cellular level, but is only one of the many signaling 
networks involved. 
Growth Factors 
Another important regulatory process in the development and health of the 
Achilles tendon centers around the transforming growth factor beta superfamily of 
molecules (Rickert et al., 2005). Within this family are a number of growth factors 
critical to the development and to the healing of Achilles tendons including growth 
differentiation factor five. The expression of these growth factors, and their effectiveness, 
is genetically determined and provides another example of an endogenous factor that 
effects Achilles tendon strength, and therefore risk of injury (Rickert et al., 2005). 
Strengthening this point, evidence shows that artificially raising the levels of growth 
differentiation factor five, achieved through gene transfection, resulted in thicker, 
stronger Achilles tendons (Rickert et al., 2005). This means that the factors that regulate 
the expression of the genes that encode these growth factors have direct effects on the 
strength and risk of injury of the Achilles tendon. 
Not every factor involved in the complicated cellular processes that dictate the 
properties of the Achilles tendon have been explored to such a process wide extent, 
however. Many of the various molecules that have an effect on the Achilles tendon have 
only been compared in healthy and unhealthy tendons. These comparisons are useful and 
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helpful in establishing the differences between a healthy and a pathologic Achilles 
tendon, but only allow correlative associations to be made, falling short of the evidence 
necessary to establish a causative effect. Nevertheless, a brief overview of these 
molecules and their lot in the healthy and unhealthy calcaneal tendon is interesting and 
worthwhile, particularly in the context of areas for potential further research. 
Insulin like growth factor is one of these influential but understudied factors 
present in the Achilles tendon that plays an important role in the growth, repair, and 
maintenance of the tissue. When insulin like growth factor is upregulated in the Achilles 
tendon the tissue undergoes considerable cell proliferation and matrix remodeling (Khan 
et al., 1999). Injured Achilles tendons have been found to have higher insulin like growth 
factor levels, indicating that the rise in cellular proliferation and matrix remodeling is an 
important component of the healing process (Khan et al., 1999). Insulin like growth 
factor is not the only signaling molecule that is present in detectably elevated levels in an 
injured Achilles tendon, with a number of cytokines and growth factors following a 
similar pattern of expression. Studies of these various factors have shown that 
individually many of these factors have regenerative or reinvigorating effects on the 
Achilles tendon, and insulin like growth factor itself was shown to increase the 
functionality and the strength of rat Achilles tendons (Molloy et al., 2003). 
Interestingly, loading of the Achilles tendon is an important regulator of insulin 
like growth factor levels (Khan and Scott, 2009). With loading, most simply and 
effectively achieved by light use, insulin like growth factor was upregulated in Achilles 
tendons measured in vitro and in vivo. These findings, that tendon use raises insulin like 
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growth factor levels, taken in conjunction with the demonstrable effect of insulin like 
growth factor and other various signaling molecules on the repair and restructuring of the 
tendon, provide one possible mechanism for the efficacy of light loading in treatment of 
Achilles tendon ruptures (Khan and Scott, 2009). 
Laminin and Fibronectin 
Less established is the role of laminin and fibronectin in the Achilles tendon. Both 
substances are normally found together within the walls of the vasculature in the 
paratenon of a normal calcaneal tendon, but not found within the tissue body of the 
tendon (Jozsa et al., 1989b). In an injured Achilles tendon, however, the distribution of 
fibronectin changes while laminin remains confined the periphery of the tendon (Jozsa et 
al., 1989b). In injured Achilles tendons, fibronectin, highlighted using peroxidase 
antiperoxidase immunochemistry, was found to be present in large quantities near the site 
of injury and also, in lesser concentrations, throughout the tissue of the tendon 
surrounding tenocytes, including in areas remote to the site of injury that otherwise 
appeared to be normal (Jozsa et al., 1989b). This permeation of fibronectin into the tissue 
of the Achilles tendon, without the accompanying spread of laminin, indicates that the 
observed effect is not simply the result of vascularization of the tissue, while the 
uniformity and ubiquity of fibronectin distribution in the tendon indicate a change that 
has occurred over some time and not as a reaction to injury (Jozsa et al., 1989b). More 
concisely, the alteration in fibronectin organization observed in injured Achilles tendons 
is likely a change that has occurred prior to injury, not in reaction to it, and might be a 
predisposing factor for injury, representing some form of dysregulation that increases the 
chances of suffering an injury (Lehto et al., 1990). The lack of laminin pervading into the 
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body of the tendon does not, however, preclude the possibility that there are important 
vascular changes surrounding an Achilles tendon injury.  
Vascular Changes 
As previously discussed, the Achilles tendon is a relatively avascular tissue that it 
is at high risk for hypo-vascular insult (Sharma and Maffulli, 2005). Study of the 
vasculature of ruptured Achilles tendons has revealed conspicuous degeneration of the 
vessels, as well as inflammatory and obliterate changes in the character of the vessels still 
remaining in the tendon (Kvist et al., 1992). The prevalence of these vascular 
transformations in injured Achilles tendons, with reportedly as high as 100% of ruptured 
Achilles tendons showing vascular degradation, is a very strong indicator that these 
changes are contributing factors to risk of Achilles tendon injury (Kvist et al., 1992). 
Surprisingly, hyper-vascularity can also have detrimental effects on the health of 
the Achilles tendon. Specifically, in the case of Achilles tendon injury, hyper-vascularity 
is associated not with frank tendon rupture as hypo-vascularity is, but with tendinopathy 
(Li and Hua, 2016). Neovascularity, or the invasion of tissue with new blood vessels, has 
been strongly associated with Achilles tendinopathy, and the invasion of these blood 
vessels and their accompanying nerves has been put forward as one possible source of the 
pain suffered by those afflicted with Achilles tendinopathy (Li and Hua, 2016). 
 Interestingly and unfortunately, the overgrowth of vasculature seen in Achilles 
tendinopathy does not increase the perfusion or oxygenation of the tendon itself. The 
theory that these extraneous invading nerves that enter the tendon following invading 
vasculature are responsible for the pain associated with Achilles tendinopathy is a 
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reasonable explanation, and the driving force behind this hyper-vascularity is likely the 
signaling molecule vascular endothelial growth factor (Li and Hua, 2016). 
Vascular endothelial growth factor (VEGF) is the most important of several 
molecular signals that trigger and guide vascular growth (Li and Hua, 2016). In hyper-
vascularized tissues of the Achilles tendon in tendinopathy sufferers, the levels of VEGF 
measured in the afflicted tendons were notably high (Li and Hua, 2016). This high 
expression of VEGF is likely the cause of the vascular neogenesis, and possibly the 
underlying cause of the Achilles tendinopathy (Li and Hua, 2016). Whether VEGF is the 
root cause of this Achilles tendinopathy, or simply one of a number of contributing 
factors, it is clear that the growth factor represents another component in one of the many 
complicated molecular signaling pathways effecting Achilles tendon health. 
Cellular Changes 
Many of the changes highlighted between pathologic and healthy Achilles 
tendons are observable at the cellular level. Many of these changes are seen in the 
tenocytes and tenoblasts themselves, but other cell types also show significant changes in 
distribution or activity when compared with their roles in healthy Achilles tendons (Khan 
et al., 1999). 
As the most numerous and most influential cells of the Achilles tendon, changes 
in tenocyte and tenoblasts character and action have the most dramatic effects on the 
tendon. In a tendinopathic Achilles tendon tenocytes, normally inconspicuous and 
sparsely distributed, are found in greater numbers and appear as plump and chondroid in 
form (Khan and Scott, 2009). These abnormally distributed and shaped tenocytes are 
associated with a sharp increase in the mucoid ground substance surrounding them, 
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contributing to the overall dysregulation and abnormal appearance of the tendon(Khan et 
al., 1999). This change in the constitution of the extracellular matrix surrounding the 
tenocytes suggests that they are hyperactive, while their distribution suggests that they 
are also hyperproliferative in Achilles tendinopathy (Khan et al., 1999). 
The number and distribution of fibroblastic and myofibroblastic cells of the 
Achilles tendon is also significantly altered in tendinopathy (Khan et al., 1999). In a 
normal and healthy Achilles tendon there are virtually no fibroblasts or myofibroblasts 
within the avascular collagenous tissue of the tendon body, but in tendons of 
tendinopathy sufferers there is an invasion of fibroblastic and myofibroblastic cells into 
the tendon tissue. These smooth muscle actin containing cells are consistent with the 
proliferative changes seen in tenocytes and tenoblasts and likely make similar 
synthesizing contributions to the changing extracellular matrix in the tendon (Khan et al., 
1999). This cellular proliferation, interestingly, also occurs in conjunction with the 
vascular invasion already discussed as an etiological factor in the development of 
Achilles tendinopathy, growing in effect as vascularity increases and, more tellingly, 
abruptly ceasing to occur beyond the limits of the neovascularized tissue (Khan et al., 
1999).  
Regardless of the specific interactions of the cells involved in this process, or the 
myriad signaling pathways that lead to the cellular invasion and propagation observed in 
Achilles tendinopathy, it is clear that there are many more cells present in a symptomatic 
Achilles tendon than in a healthy tendon. Those cells are specifically tenocytes, 
tenoblasts, and fibroblastic cells involved in synthesis and secretion of extracellular 
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matrix substances. Conspicuously absent from this hypercellular influx are the cells most 
commonly seen in injured tissue, inflammatory and immune cells. These inflammatory 
and immune cells are found in injured Achilles tendons, but in ruptured tendons not 
tendinopathic tendons (Li and Hua, 2016).  
Inflammatory Response 
Following a rupture, the Achilles tendon undergoes a series of processes 
involving inflammatory and immune cells, tenocytes and tenoblasts, and vascular 
alterations that eventually lead to healing of the wound (Li and Hua, 2016). The first step 
in this process is similar to the response to injury seen in other tissues throughout the 
body. Immediately following injury, inflammatory cells begin to migrate to the site of the 
wound where they release vasoactive and chemotaxic factors (Li and Hua, 2016). These 
chemicals signals amplify the initial inflammatory response and also induce vascular 
changes that aid and encourage this response. The chemical mediators released by these 
invading cells then trigger the proliferation and activation of tenocytes and tenoblasts (Li 
and Hua, 2016). These endemic tendon cells, present within the tendon before injury, are 
triggered by the complicated pattern of chemical signals generated by local and invasive 
cells under chemical and mechanical influences and begin to produce the collagen and 
other extracellular material necessary for the repair of the tendon (Li and Hua, 2016). 
The tenocytes and tenoblasts involved in this process are local cells, often 
migrating from no farther than the epitenon to the site of injury under the influence of the 
aforementioned signaling processes (Li and Hua, 2016). Initially, following a rupture, 
these cells are responsible for laying down a network of type III collagen which serves as 
the framework for the repaired tendon. Following this first phase of repair the tendon 
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undergoes large scale remodeling with resorption and secretion of various extracellular 
matrix substances including various types of collagen and glycosaminoglycans (Li and 
Hua, 2016). Eventually the remodeling process reaches a point where the majority of 
collagen fibers are arranged longitudinally with the main axis of the tendon and the 
cellularity of the tendon returns to normal, however the tendon never truly returns to its 
original pre-rupture strength or microscopic organization (Li and Hua, 2016).  
Organizational Disruptions 
Permanent alterations in the structure of the Achilles tendon following rupture are 
observable, and most apparent in the organization of the collagen fibers themselves 
(Ribbans and Collins, 2013). Disruptions in collagen structure, particularly in caliber and 
crimping of the fibers, are in fact visible defects that are suggestive of overall tendon 
weakness (Ribbans and Collins, 2013). As discussed before, collagen fibers of the 
Achilles tendon exist in a highly organized hierarchical latticework. This organization is 
integral to the strength and functionality of the tendon and problems in collagen character 
or structure are often found in association with Achilles tendon injury (Sharma and 
Maffulli, 2005). 
One cause of collagen defects is genetic polymorphisms that alter the production 
of collagen or the collagen itself (Ribbans and Collins, 2013). Many genetic defects that 
alter the production and quality of collagen are well known, and lead to equally well 
know disorders with consequences far beyond the Achilles tendon. These include the 
genetic changes that lead to syndromes like osteogenesis imperfecta, and Ehlers Danlos, 
both of which are associated with a much higher risk of Achilles tendon injury (Ribbans 
and Collins, 2013). 
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Genetic malfunction also presents a possible explanation for the higher incidence 
of Achilles tendon injuries experienced by people with type O blood. The gene COL5A1, 
one of the genes responsible for encoding type V collagen, is located downstream of the 
ABO blood group gene on chromosome nine (Ribbans and Collins, 2013). This proximity 
represents a link between ABO blood group and collagen type V expression, with the 
specific ABO groups associated with injury representing possible markers of specific 
genetic patterns in the COL5A1 gene that lead to higher risk of injuries (Ribbans and 
Collins, 2013). 
Collagen type V is a relatively minor protein in the Achilles tendon by weight, but 
is essential to the formation of the type I collagen fibers that make up the majority of the 
tendons (Ribbans and Collins, 2013). Overexpression or under expression of type V 
collagen results in damaging alterations in type I collagen fibers, resulting in increased 
risk of injury. Genetic dysregulation of this protein, possibly due to defects associated 
with specific ABO groups, are likely the reason for a higher incidence of injury amongst 
type O blood populations (Ribbans and Collins, 2013). 
Any change that results in disrupted collagen structure, regardless of the etiology 
of the change, leads to an increased risk of Achilles tendon injury. This point is clearly 
demonstrated in studies of the pattern of collagen deposition in healthy and unhealthy 
Achilles tendons. Healthy Achilles tendons appear white and shiny, while pathogenic 
tendons appear uneven and brownish (Li and Hua, 2016). This is likely a reflection of the 
differing patterns of collagen fibers observed microscopically in comparisons of healthy 
and injured tendons.  
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Healthy Achilles tendon collagen fibers appear in a uniform and wavelike pattern 
with an established angle formed by the waves in the collagen fibers (Figure 4) (Järvinen 
et al., 2004). Unhealthy Achilles tendons, particularly Achilles tendons that have suffered 
a rupture, demonstrate far less uniformity, with irregular angles, loss of the wavelike 
pattern, and sometimes loss of parallel fiber arrangement (Järvinen et al., 2004). 
Loss of this wavelike pattern and uniformity can be a result of cellular changes 
leading to alterations in the collagen fibers themselves or a result of mechanical action of 
the tendon (Kader et al., 2002). Stretching or straining the fibers of a tendon beyond four 
percent of their original length results in loss of this pattern, while stretching beyond 
eight percent of original length results in frank rupture of the fibers (Kader et al., 2002). 
This provides further evidence that overuse, or putting irregular strain on the Achilles 
tendon raises the risk of injury, likely through this pattern disruption pathway. 
 
Figure 4: 
Wavelike Pattern of Collagen in Achilles Tendon The wavelike pattern of collagen 
fibers, often described as waviness or crimping is labeled in archetypical areas with *** 
(Järvinen et al., 2004). Image taken from (Nephron, 2012). 
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Even more indicative of the damaging effects of the loss of collagen fiber pattern 
on the Achilles tendon is the finding that the irregularity of collagen fiber size, direction, 
and wave-angle increases in both frequency and deviation with proximity to the site of 
injury (Järvinen et al., 2004). This realization indicates that not only is an Achilles tendon 
with disorganized collagen fibers far more likely to undergo rupture, but is likely to 
rupture in the area of greatest disorganization, suggesting again that it is this loss of 
organization that is directly responsible for the loss of function in the tendon (Järvinen et 
al., 2004). 
 
Incidence 
Achilles tendinopathy is a common injury particularly in the western world, 
representing the most commonly reported chronic injury of the ankle and foot across 
54,851 athletes studied and the subject most commonly examined across 89 studies 
reviewed between 1982 and 2010, with 44% of studies focusing on Achilles tendinopathy 
(Sobhani et al., 2013). Tendinous injuries are common amongst athletes, and with an 
increasingly sports involved population in the western world tendon injuries are 
becoming more and more prevalent (Sobhani et al., 2013). Male orienteering runners, for 
example, have a ten times greater age adjusted risk of developing Achilles tendinopathy 
than their non-running counterparts. In fact, an estimated 30% to 50% of all sports related 
injuries are attributed to tendon problems, and a large number of those tendinous injuries 
are Achilles tendinopathies (Järvinen et al., 2005). This correlation helps to explain the 
sharply increasing incidence of Achilles tendinopathies in the increasingly athletically 
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involved western populations, but should not overshadow the increasing occurrence of 
Achilles tendinopathy in the general population.  
The calcaneal tendon is, in fact, the single most ruptured tendon in the body and 
calcaneal tendon rupture is becoming an ever more frequent occurrence amongst athletes 
and non-athletes (Egger and Berkowitz, 2017a; Jozsa et al., 1989a). In contrast to other 
Achilles tendinopathies that are considered chronic injuries, Achilles tendon rupture is 
associated with racquet and ball sports and seen as an acute injury (Schepsis et al., 2002). 
Calcaneal tendon rupture most frequently occurs in active middle aged men in their 
fourth and fifth decade of life, with a second peak in ruptures occurring in the eighth 
decade(Schepsis et al., 2002). Using northern European patient populations, a number of 
studies have shown that the incidence of Achilles tendon ruptures has increased in each 
of the last four decades (Egger and Berkowitz, 2017b). Between 2001 and 2012 the 
incidence of Achilles tendon ruptures in Sweden rose 17% for men (to more than 1 in 
2000 people affected), while an even higher 22% increase was reported for women 
(Egger and Berkowitz, 2017b).  
While Achilles tendon rupture is commonly considered in the light of sports, there 
are many other predisposing factors that have been shown to be associated with injury 
that are not unique to athletes, but seen across many demographics. These include a 
previous history of gout, treatment with fluoroquinolone antibiotics, type O blood, 
previous corticosteroid injection, forefoot varus, and high longitudinal arches (Schepsis et 
al., 2002).  
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Intrinsic factors also significantly contribute to increasing the chances of Achilles 
tendon rupture. A slow and pathologic degeneration of the calcaneal tendon of unknown 
origin can occur, and was found to be present in as much as 50% of patients prior to the 
acute rupture as determined by histological study post rupture (Jozsa et al., 1989a). 
Recurrent microtrauma to the rupture site and improper healing have also been proposed 
as a precipitating factor in calcaneal tendon rupture but, as Schepsis et al. indicate, the 
lack of prodromal signals and rapid onset of symptoms concurrent with the rupture seem 
to suggest that this, at least in the majority of cases, is truly an acute injury without a 
history of improper healing (Schepsis et al., 2002). 
A further and even more significant factor leading to the increased incidence of 
Achilles tendon rupture is the increased risk of injury that comes with more demanding 
use of the Achilles tendon. Simply put, Achilles tendon injury, and specifically rupture, is 
far more likely to occur in individuals that put more stress upon their Achilles tendons 
more often (Schepsis et al., 2002). This explains the higher incidence of Achilles 
tendinopathy amongst athletes, and upon further investigation of these athletes, the link to 
the general population becomes apparent.  
Achilles tendon ruptures as sports injuries occur overwhelmingly as a result of 
acceleration or deceleration, with changes in velocity leading to as much as 90% of 
calcaneal tendon ruptures in sports (Soldatis et al., 1997). These motions are not unique 
to sports, however, but instead represent movements of day-to-day active life that are 
exaggerated or accentuated in sports. As the population of the western world continues to 
remain active later in life, the starting and stopping motions of everyday life become 
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relatively more significant to an aging body, becoming increasingly similar to the 
acceleration and deceleration seen in sports, and leading to the higher incidence of 
Achilles tendon rupture observed in the fourth and fifth decade of life (Schepsis et al., 
2002). 
This increasing risk with age is compounded by the fact that Achilles tendon 
rupture is often an injury associated with fatigue (Schepsis et al., 2002). Athletic injury of 
the Achilles tendon usually occurs after some period of exercise, typically thirty minutes 
or more into the activity. This indicates that the risk of Achilles tendon rupture rises when 
the tendon is fatigued (Schepsis et al., 2002).  
Non-rupture Achilles tendinopathies also follow this pattern, with the highest risk 
for chronic Achilles tendon injury being associated with running too great a distance, at 
too great an intensity, or with too rapid an increase in the distance or intensity of 
workouts (Järvinen et al., 2005). Each of these conditions increases the risk of injury by 
increasing fatigue, indicating that a tired tendon is the tendon most likely to suffer an 
injury. 
These trends make sense in the context of the biomechanical properties of the 
Achilles tendon already discussed. Creep and stress relaxation (see biomechanics section) 
are both fundamental physical properties of the Achilles tendon and, upon further 
consideration, provide one explanation for this rise in Achilles tendon injuries with 
fatigue and rapid increases in use (Sharma and Maffulli, 2005). As forces are applied 
across the tendon in normal use, the tissue undergoes stress relaxation and creep under 
those forces. When the forces are removed, a standard part of normal gait, the tissue 
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recovers to its original dimensions. In the cases that lead to higher risk of injury, too 
taxing or too much exercise, this recovery time is altered (University of Texas at Austin, 
n.d.). In high intensity activity, when higher than normal forces are applied across the 
Achilles tendon, the tissue undergoes stress relaxation, but because the relaxation is so 
great to counteract the greater forces, does not have enough time to fully recover between 
forces. This leads to a cumulative effect increasing the deformation of the Achilles 
tendon and leading to a higher risk of injury (University of Texas at Austin, n.d.). 
In the case of increasing duration of exercise, it is the phenomenon of creep that 
helps to explain increasing risk of injury. During long periods of heavy use, the average 
force across the Achilles tendon causes the phenomenon of creep in the tissues. As the 
tendon in used for longer periods of time, as in longer duration exercise, this creep grows, 
eventually leading to deformation of the tissue and higher risk of injury (University of 
Texas at Austin, n.d.). Again the risk of injury can be seen to greatly rise in fatigued 
tissue.    
This high risk associated with fatigue is another factor whose effect can be seen in 
conjunction with the aging active population as an explanation the rising incidence of 
Achilles tendinopathy in the general population. In the same way that accelerating and 
decelerating actions in daily life become more strenuous as bodies age and consequently 
become more like the actions seen in sports that lead to risk of calcaneal tendon rupture, 
the day-to-day actions of life become more and more tiring to an aging body and 
contribute to a state similar to that experienced by fatigued athletes, raising the risk of 
calcaneal tendon rupture with regular use (Sharma and Maffulli, 2005). This means that 
 34 
the aging population of the western world staying active for longer, even maintaining 
levels of activity below those traditionally considered to be attained in athletics, is a 
major factor contributing to the rising risk of Achilles tendon injury observed. 
This rising risk of Achilles tendinopathy is a population wide phenomena, the 
result of many factors including changes in lifestyle, diet, and access to fluoroquinolones 
in the western world. Remarkably, there is a nearly six percent lifetime chance of 
suffering an acute rupture of the Achilles tendon, and more than twenty people in every 
thousand will suffer, at some point in their lives, some form of Achilles tendinopathy 
outside of a frank rupture (Kujala et al., 2005). These numbers are even higher amongst 
athletes, with nearly a quarter of all athletes enduring some kind of Achilles tendinopathy 
during the course of their lives (Kujala et al., 2005). These incidences are only rising, 
with active aging populations, participation in sports, easy access to fluoroquinolone 
antibiotics, and common consumption of diets leading to gout all factors likely to be on 
the rise as countries around the world become more developed and people around the 
world have more time for recreation and leisure.  
Compounding this issue is the finding that increased BMI is correlated with 
increasing symptoms of Achilles tendinopathy after suffering an initial injury (Olsson et 
al., 2014). That is to say, patients with higher BMIs have more and worse symptoms 
when they suffer a calcaneal tendon injury (Olsson et al., 2014). The obesity epidemic in 
the western world, and rising BMIs around the world, are well documented, and suggest 
that Achilles tendinopathy symptoms will worsen in the future.  
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Classification and Treatment of Achilles Tendon Injuries 
Achilles tendon injuries can be divided into more differentiating categories than 
the simple rupture and non-rupture groups often used in epidemiological discussions. 
These broad distinctions, of rupture and of other, are useful in separating out the most 
disparate of the many calcaneal tendon injuries, helpful because the Achilles tendon 
rupture, which is plainly different from other injuries, follows its own course and occurs 
with differing frequency than other calcaneal tendinopathies (Asplund and Best, 2013; 
Weinfeld, 2014; Zwiers et al., 2016).  
Ruptures of the Achilles tendon are further divided into the familiar and apparent 
categories used commonly for all tendon ruptures: partial and complete (total) rupture, 
but more nuanced system of classification can be imposed upon non-rupture Achilles 
tendinopathies by making use of the anatomical features of the calcaneal tendon (Asplund 
and Best, 2013; Weinfeld, 2014; Zwiers et al., 2016).       
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Figure 5: Achilles Tendon Anatomy and Insertion The Achilles tendon traces the 
posterior margin of the lower leg before passing between the retrocalcaneal bursa 
anteriorly and the calcaneal bursa posteriorly and inserting into the calcaneus (Asplund 
and Best, 2013; Wiegerinck et al., 2013; Zwiers et al., 2016). Image taken from 
(Tourism, 2015). 
 
The Achilles tendon traces the posterior margin of the lower leg before passing 
between the retrocalcaneal bursa anteriorly and the calcaneal bursa posteriorly and 
inserting into the calcaneus (Figure 5) (Asplund and Best, 2013; Weinfeld, 2014; Zwiers 
et al., 2016).  
Based upon this anatomical insertion of the Achilles tendon into the calcaneus 
bone of the heel, the more determinate system of classification breaks Achilles 
tendinopathies into insertional and non-insertional injuries with an important distinction 
being made for injuries that occur in the midportion of the tendon, classified as 
midsubtance, or, more anatomically, midportion injuries (Asplund and Best, 2013; 
Weinfeld, 2014; Zwiers et al., 2016). 
Midportion Achilles Tendinopathy  
The region of poor perfusion, located two to six centimeters above the insertion of 
the Achilles tendon into the calcaneus, forms a clinically relevant and distinct portion of 
the tendon characterized by a low proclivity for healing injuries (Asplund and Best, 2013; 
Weinfeld, 2014; Zwiers et al., 2016). This poorly perfused region corresponds almost 
exactly with the area of the calcaneal tendon afflicted in midportion (sometimes referred 
to as midsubstance) injury (Zwiers et al., 2016).        
This poor proclivity for healing is the hallmark characteristic of midportion 
Achilles tendon injury and is the primary justification for the strong distinction that is 
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made between midportion tendon injuries and other calcaneal tendon injuries (Zwiers et 
al., 2016). Unsurprisingly, particularly when considering the increased risk for injury 
associated with the poor blood-flow to the region, midsubstance Achilles tendon injuries 
are more common than their insertional counterparts (Asplund and Best, 2013). 
Midportion Achilles tendinopathies make up not only the single largest category of 
calcaneal tendinopathies, but a majority of these injuries, representing 55% to 60% of 
Achilles tendinopathies (Asplund and Best, 2013).   
Insertional Achilles Tendinopathy 
Insertional Achilles tendinopathies are the next most common category of 
calcaneal tendinopathies, comprising 20% to 25% of calcaneal tendinopathies (Asplund 
and Best, 2013). These injuries are often the result of degradation of the Achilles tendon 
at, or very near to, the point of insertion into the calcaneus. This degradation may or may 
not be accompanied by calcification of varying degrees (Weinfeld, 2014). Other 
complications are also common co-occurrences with insertional Achilles tendinopathy.  
The Achilles tendon is often observed to be inflamed and thickened in insertional 
calcaneal tendinopathy, resulting in painful tenderness as well as poor healing local to the 
insertion (Weinfeld, 2014). A Haglund’s deformity, characterized by a bony projection of 
the calcaneus extending posteriorly into the Achilles tendon inferior to the retro calcaneal 
bursa (Figure 6), is often seen in conjunction with insertional Achilles tendinopathy as 
well (Weinfeld, 2014). This comorbidity contributes to worsening insertional Achilles 
tendinopathy by putting pressure on the insertion of the tendon, and also by acting as a 
fulcrum for the Achilles tendon, disrupting its biomechanics and increasing the forces 
across the tendon (“Haglund’s Deformity,” 2017; Weinfeld, 2014).  
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Figure 6: Bony Prominence of Haglund’s Deformity: The bony projection of 
the calcaneus extending posteriorly into the region normally occupied by the Achilles 
Tendon. Interestingly, this deformity is often referred to casually as a “pump bumb,” as it 
results in a prominent bump on the posterior of the heel in the location that the rear of a 
woman’s “pump” style shoe would cross. It has been proposed that one source of 
irritation leading to the growth of this bony prominence is increased pressure due to 
frequent use of hard backed footwear (“Haglund’s Deformity,” 2017; Weinfeld, 2014).  
 
Other Achilles Tendinopathies 
The remainder of Achilles tendinopathies are non-insertional and non-
midportional. This group of comparatively less common afflictions of the Achilles tendon 
and related structures include subcutaneous calcaneal bursitis, retrocalcaneal bursitis, 
paratenonitis, and others (Saini et al., 2015). These infrequent and poorly studied 
calcaneal tendinopathies are less common than their midportion and insertional 
counterparts (Saini et al., 2015).  
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The most notable of these less common and less concerning Achilles 
tendinopathies is paratenonitis. This condition is defined by a degeneration of the highly 
vascularized paratenon sheath surrounding the Achilles tendon (Saini et al., 2015). 
Occurring frequently in conjunction with insertional Achilles tendinopathy, paratenonitis 
can occur independently of insertional tendinopathy and is often seen in professional 
dancers or long distance runners. This can be a painful condition, resulting in a swollen 
and tender posterior lower leg, and much of the treatment for this condition focusses on 
dealing with reducing inflammation and alleviating symptoms (Saini et al., 2015).  
In Paratenonitis imflamatory cells, as well as capillary expansion, can be observed 
within the paratenon tissue. Either directly as a result of, or in concert with, these 
changes, myofibroblasts of the paratenon begin to enact a stress response synthesizing 
and excreting collagen (Weinfeld, 2014). This process results in a stiffening and 
constricting of the paratenon that can lead to severely reduced blood flow to the Achilles 
tendon (Weinfeld, 2014). This diminished blood flow to the Achilles tendon, already at a 
high risk of hypovascular insult, can be quite detrimental and lead to the development of 
other Achilles tendinopathies (Weinfeld, 2014). 
Treatment of Achilles Tendinopathy 
Treatment of midportion Achilles tendon injury is varied, with many 
methodologies and strategies discussed in the literature. Most of the debate over these 
strategies has focused upon methods of weight bearing and intentional therapies (Couppé 
et al., 2015; Gross et al., 2013; Kearney et al., 2015). Light exercise has long been 
understood to have rehabilitation effects on Achilles tendinopathies, and current studies 
have focused on determining the most effective exercise routines for therapy (Couppé et 
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al., 2015). These exercise based rehabilitation studies have focused upon comparisons of 
eccentric and concentric routines, but no clearly superior method has been established 
(Couppé et al., 2015).  
Injectional therapies for Achilles tendinopathies have also been explored, 
including platelet rich plasma, protease inhibitor, autologous blood, and sclerosing agent 
injections with inconclusive results (Gross et al., 2013; Kearney et al., 2015). Several 
reviews of these therapies have independently concluded that there is insufficient and 
conflicting evidence of the efficacy of these injectable treatments, indicating that further 
study in this area would be a valuable contribution to the field (Gross et al., 2013; 
Kearney et al., 2015).     
In light of these findings, treatment for midportion calcaneal tendon injury 
remains a complicated and challenging endeavor (Zwiers et al., 2016). The one unifying 
characteristic, however, common to nearly all midsubstance Achilles tendon injuries is 
that they are managed conservatively, with a focus on load reduction and pain 
management (Asplund and Best, 2013). Surgical treatment of Achilles tendinopathy has 
been found to be successful, but not necessarily more successful than conservative 
treatment options, and therefore is avoided due to higher risk of complications (van der 
Eng et al., 2013; Vulpiani et al., 2003).  
Treatment of insertional tendinopathies of the Achilles tendon are less studied 
than their midporiton counterparts, most likely due to the differing frequencies of the two 
injuries. Nevertheless, significant resources have been used to study the treatment of 
insertional calcaneal tendinopathies, often focusing on the application of similar methods 
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of treatment to those used successfully in caring for midsubstance tendinopathies (Roche 
and Calder, 2013). These attempts have met with modest success, but have not been as 
successful in treating insertional Achilles tendinopathy as in treating midportion 
calcaneal tendinopathy (Roche and Calder, 2013). What is clear from studies of 
management of insertional Achilles tendinopathy is the importance of identifying and 
treating any concurrent problems associated with the injury including tendon 
calcification, tendon degradation, and Haglund’s deformity (Roche and Calder, 2013). 
Achilles Tendon Ruptures 
Outside of these categories, insertional and non-insertional Achilles 
tendinopathies is rupture, the most egregious and drastic subgroup of Achilles tendon 
injuries. Achilles tendon ruptures are most often viewed as acute injuries, the result of a 
sudden injury, often precipitated by a specific action or event. These acute ruptures are 
responsible for the majority of Achilles tendon ruptures and can be sub classified into 
incomplete rupture and full ruptures depending upon the amount of tendon thickness 
ruptured (Saini et al., 2015). These are not the only ruptures of the Achilles tendon 
observed, however, as a chronic Achilles tendon rupture is possible. Chronic rupture of 
the calcaneal tendon occurs over the course of four to six weeks following an injury 
(Saini et al., 2015).  
Complete Rupture of the Achilles Tendon 
Complete rupture of the Achilles tendon most frequently occurs in a single 
moment. Commonly taking place during activity, particularly sports and athletics that 
require rapid changes in velocity or vertical leaping, complete rupture of the Achilles 
tendon is a sudden and painful injury, routinely leaving patients unable to walk 
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immediately following the injury (Weinfeld, 2014). Patients usually report a sudden pain 
that feels like they were “shot” or “struck” on the heel, sometimes accompanied by a 
“popping” sound (Weinfeld, 2014). This history suggests an Achilles tendon rupture to 
the clinician, a diagnosis that is usually confirmed with palpitation of a disconnect in the 
calcaneal tendon, but sometimes requires imaging to confirm (Weinfeld, 2014).  
Incomplete and Chronic Ruptures of the Achilles Tendon 
Incomplete ruptures of the calcaneal tendon, rupture of less than the full thickness 
of the tendon, represent the other major category of Achilles tendon rupture (Asplund and 
Best, 2013). Occurring in a similar manner and in similar circumstances as total tendon 
ruptures, partial calcaneal tendon ruptures can also be challenging to manage injuries, and 
are considered acute injuries (Asplund and Best, 2013).  
Chronic Achilles tendon ruptures, the third and least common type of Achilles 
tendon rupture, are distinct in their history and clinical presentation, and consequently 
present their own treatment challenges (Weinfeld, 2014). Chronic Achilles tendon 
ruptures can be partial or complete ruptures that either occur, by definition, over the 
course of more than four weeks, or are neglected for four or more weeks (Weinfeld, 
2014).  
Treatment of Achilles Tendon Ruptures 
Treatment of a complete rupture of the Achilles tendon is a widely debated topic. 
There is an array of approaches used to treat calcaneal tendon rupture, both surgical and 
nonsurgical, that have proved to be promising and successful methods (Asplund and Best, 
2013; Weinfeld, 2014). Some important factors that have been studied in attempts to 
elucidate a clear standard treatment include rupture rate, chance of complication, and rate 
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of recovery. None of these factors, however, have conclusively shown one method of 
treatment to be superior to others (Cooper, 2015; Del Buono et al., 2014; Holm et al., 
2015; Li et al., 2016; van der Eng et al., 2013; Wilkins and Bisson, 2012). These studies 
are conflicting, some indicating that minimally invasive surgery is the most promising 
treatment, others indicating that conservative management is best, and others still 
suggesting that open surgery is the treatment most likely to lead to complication free 
recovery of Achilles tendon rupture (Volpin, and Maffulli 2014; van der Eng et al. 2013; 
Cooper 2015; Q. Li et al. 2016). One proposed explanation for this discordant literature is 
the importance of post repair rehabilitation in Achilles tendon ruptures. The suggestion is 
that the rehabilitation is far more important than the repair, thus explaining the similar, or 
not significantly differing outcomes of various repair techniques (Volpin, and Maffulli 
2014; van der Eng et al. 2013; Cooper 2015; Q. Li et al. 2016). The clearest point that can 
be gleamed simply from this large and dissenting body of work is that treatment of a 
complete Achilles tendon rupture is a complicated and involved process that would 
benefit from further study (Asplund and Best, 2013; Saini et al., 2015; Weinfeld, 2014). 
Similar to the study that has been done of insertional Achilles tendinopathy, much 
of the investigation into the treatment of partial ruptures of the Achilles tendon has 
consisted of applying the same techniques used to manage complete Achilles tendon 
ruptures (Asplund and Best, 2013). Like full ruptures, the results of these studies are 
inconclusive and contradictory, illustrating the need for further investigation (Volpin, and 
Maffulli 2014; van der Eng et al. 2013; Cooper 2015; Q. Li et al. 2016). There is, 
however, a noticeably stronger indication for surgical intervention in the case of partial 
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ruptures than for conservative management treatments which is not paralleled in the 
literature for full rupture treatments (Asplund and Best, 2013).  
These categories represent a framework used within the literature and in clinical 
practice to distinguish and group the various Achilles tendon injuries that occur. This 
categorical framework is useful in clinical diagnosis and management of Achilles tendon 
injuries, and also serves as a reference for sorting and classifying the plethora of 
dissenting research published on Achilles tendon injuries.  
Outcomes 
Achilles tendinopathy can be a devastating injury, and often does not result in a 
full recovery. This is particularly true within the population of athletes participating in 
sports that require rapid changes in velocity who are at an elevated risk of injury. This 
trend is most striking when looking at elite professional athletes (Amin et al., 2013). In a 
study of professional basketball players playing in the National Basketball Association 
who suffered complete rupture of the calcaneal tendon, 39% of athletes never made a 
return to play after their injury. Outcomes look even more bleak when player 
performance is considered. National Basketball Association players who suffered an 
Achilles tendon rupture and did return to play showed a significant drop in standardized 
statistics to measure player performance, as well as significant reductions in playing time 
(Amin et al., 2013). These considerable drop offs in both performance measures and 
playing time are indicative of the severity of an Achilles tendon rupture for an elite 
athlete, showing that not only is there a significant chance of never returning to play after 
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rupturing a calcaneal tendon, but even with a return to play it is highly improbable that an 
athlete will return to the same level of performance that was achieved before the injury.  
This somewhat discouraging outlook is not unique to National Basketball 
Association players, and can be seen even more distinctly in other elite athletes. 
Professional football players playing in the National Football League who suffered 
calcaneal tendon ruptures were studied over a five-year period during which 32% of 
players never returned to play after their injury. Even more striking is the observed drop 
in performance measuring statistics. Across all positions a greater than 50% reduction in 
power rating was found for players returning from Achilles tendon rupture over a three-
year period, with the positions requiring rapid accelerations and decelerations seeing the 
greatest drop in performance statistics(Parekh et al., 2009). Linebackers, wide receivers, 
and cornerbacks, for example, were found to have a 95%, 88%, and 87% decrease in the 
performance measuring statistic power rating respectively over a three-year time course 
(Parekh et al., 2009). These dramatic drops in performance seen over the span of years, 
along with the high chance of never returning to play, are discouraging indicators of the 
devastating effect of calcaneal tendon rupture on elite athletes competing at the 
professional level.  
For professional athletes this is a clear indication of Achilles tendinopathy a 
career threatening injury in some cases, and in all cases a severe hindrance to 
performance. Elite athletes are not the only population that experience such impediment 
to regular activity following Achilles tendon injury, however, with similar outcomes 
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observed in the general population, albeit to a lesser degree subsequent to the lesser 
degree of physical performance required for the general population. 
Standard care for Achilles tendon rupture rehabilitation, regardless of the method 
used to treat the acute injury, has traditionally involved a serious of casts used to 
immobilize the ankle joint in an extended (equinus) position, gradually returning to a 
more natural flexed position over the course of six to eight weeks. This serial casting 
which maintains the calcaneal tendon in a relaxed position, is followed by the use of a 
walking boot, eventually a return to light exercise, and a full return to running and 
jumping after six months (Schepsis et al., 2002). 
 The time course for this treatment is quite variable, however. In a review of more 
than 6000 patients who suffered Achilles tendon rupture across 108 studies, Zellers et al. 
investigated the time required for patients to achieve their desired goal of return to play 
was, on average, six months, but could extend to as long as 145 months in some cases 
(Zellers et al., 2016). More than twelve years of rehabilitation and healing before 
returning to play following a calcaneal tendon rupture obviously indicates that the injury 
can be an extremely hindering event.  
Even excluding what could perhaps be called extreme cases, the average time 
away from prior activity of six months following an Achilles tendon rupture represents a 
significant and intrusive period of time in the lives and routines of patients. Additionally, 
weakness and decreased stamina was found to persist in the injured leg for as long as ten 
years after the injury, exemplifying an aspect unconsidered by many of the studies 
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reviewed, namely the quality of return to play experienced by patients with Achilles 
tendon ruptures (Zellers et al., 2016).  
Undergoing treatment for and subsequently living through the process of recovery 
from Achilles tendon injury is no insignificant matter, and can have far reaching impacts 
on patients’ quality of life and work. Hopkins et al., after systematically reviewing a 
series of studies and surveys focusing on tendinopathies in an attempt to determine the 
socio-economic impact of the injury, concluded that the “productivity loss and disease 
compensation associated with tendinopathy [is] remarkable” in its depth and 
pervasiveness in society (Hopkins et al., 2016). 
While an encouraging 80% of the patients retrospectively observed by Zellers et 
al., across 108 studies did eventually return to play, the standards used to define return to 
play were not entirely consistent across all the studies, and often not as demanding as one 
would assume. Unsurprisingly, the return to play rates were significantly higher (p<.001) 
in studies with less stringent or simply indeterminate definitions of “return to play,” 
leaving Zellers calling for a standardized and reliable method to determine return to play 
(Zellers et al., 2016). Like the professional athletes discussed previously, it is important 
to consider the quality of play after return to play when reviewing the impact of Achilles 
tendinopathy on patients’ lives.  
One suggested method for evaluating the quality of this return is the Achilles 
Tendon Total Rupture Score. This metric is a patient reported instrument that asks for a 
numerical quantification of patients’ perceived limitations with a variety of activities 
following calcaneal tendon rupture (Egger and Berkowitz, 2017b). Working with this 
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Achilles Tendon Total Rupture Score has shown that patients who suffer total calcaneal 
tendon ruptures have significant functional deficits on the injured side two years after 
treatment irrespective of the treatment received. Furthermore, very little improvement 
was shown to occur between the one and two year post injury evaluations, indicating that 
the majority of healing and return to function occurs within the first year of treatment 
(Olsson et al., 2011). This corroborates the idea that the most recovery after an Achilles 
tendon rupture occurs soon after the injury and treatment, and that beyond the first year it 
is unlikely that patients will continue to improve, rarely if ever reaching pre injury levels 
of ability. 
This paradigm is substantiated by Horstman’s finding upon examination of 
patients who had suffered Achilles tendon ruptures ten years after their injuries and 
treatment. Patients demonstrated clinically recognizable deficits in strength, endurance, 
and activity of muscles in the lower limb ipsilateral to the Achilles tendon injury 
(Horstmann et al., 2012). Deficits were also observed in ankle range of motion, calf 
circumference, and maximum torque generation in the leg that had suffered a calcaneal 
tendon rupture (Horstmann et al., 2012). All of these factors provide strong evidence for 
the idea that even when patients do return to play after an Achilles tendon rupture it is at 
a lower level, and that this dearth persists for at least ten years, and more likely the 
duration of the patient’s life. 
Curiously, the patients that Horstman at el studied did not report that they felt any 
deficits in their previously injured limb. Despite the observable and objective differences 
between their limbs, patients understood themselves to have fully returned to pre injury 
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levels of activity and ability (Horstmann et al., 2012). This inclination was shared by the 
patients that Olsson et al. studied using the “Achilles Tendon Total Rupture Score” 
(Olsson et al., 2011). Patients examined using this self-reported metric considered 
themselves to be relatively healed two years post injury, reporting high level outcomes 
despite measurable persistent deficits (Egger and Berkowitz, 2017b). Patients 
encouragingly positive outlooks, despite the empirical findings of researchers, indicate 
that although Achilles tendon rupture is an injury that leaves the lower leg permanently 
weaker, smaller, and with less stamina, these shortfalls are well compensated for, and 
most patients are unaware of them (Egger and Berkowitz, 2017b; Horstmann et al., 2012; 
Olsson et al., 2011). 
This compensation, unfortunately, is not a harmless development following 
Achilles tendon injury. Patients naturally overcome the lasting consequences of Achilles 
tendinopathies on day-to-day life and even in athletics at a sub-professional level by 
masking the defects in lower leg size, stamina, and function found after an injury. 
However, these compensatory mechanisms do not address the underlying physical and 
physiological changes that occur following calcaneal tendon rupture. 
In fact, there are several indications that patients are at a greater risk of injury 
following an Achilles tendon rupture, even many years after treatment and 
“recovery”(Arøen et al., 2004). In an examination of 168 tendon ruptures Arøen et al. 
found that there was a significantly higher risk of knee injury following a calcaneal 
tendon rupture, as well as an increased risk of contralateral Achilles tendinopathy 
following rupture (Arøen et al., 2004). These are both concerning ideas, and further 
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demonstration of the severe effects an Achilles tendon rupture can have on the lives of 
patients. 
 Higher chance of injury spreading beyond the ankle joint, to the knee and 
contralateral ankle, is also indicative of the body wide affects a calcaneal tendon rupture 
can have. It is not clear whether this increased risk of injury is the result of the increased 
workload across other joints due to the weakened and flawed post-rupture Achilles 
tendon, or a result of the altered biomechanics and gait consequent to the compensatory 
changes in the body following an Achilles tendon rupture (Arøen et al., 2004). It is not 
necessary to determine which of these factors is the true underlying cause of the 
increasing likelihood of injury to appreciate the lifelong consequences of Achilles tendon 
rupture, and most likely the effects observed are a result of a combination of many 
different factors including both deficient healed tendon function and compensatory 
changes enacted to overcome this deficit. 
These lasting consequences beyond the site of injury are not exclusive to total 
calcaneal tendon rupture, however, with significant lasting remote consequences 
observed following other Achilles tendinopathies (Heales et al., 2014). In an examination 
of bilateral motor and sensory neuron involvement concurrent with unilateral 
tendinopathy across 20 studies, Heales et al. found there to be a significant difference in 
size between tendons contralateral to afflicted tendons and matched controls (Heales et 
al., 2014). Once again this is a strong indicator of the non-localized effects of Achilles 
tendinopathy, and a further example of the detrimental effects it can have on the body as 
a whole.  
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CONCLUSIONS 
Achilles tendon injuries represent a subset of injuries that can, either suddenly or 
of the course of time, lead to hindering, distracting, and debilitating interruption of daily 
life. This class of injuries is common, particularly amongst athletes and an increasingly 
active aging population of the western world, with every indication pointing to a 
continued rise in the incidence of these injuries. Divided into partial and complete 
ruptures or tendinopathies, Achilles tendon injuries can be devastating and lasting 
problems for sufferers, with lingering effects persisting for decades or more and 
pervading the entire lower body. Achilles tendinopathies are themselves divided into 
insertional and non-insertional pathologies, the most notable of the second category being 
midsubstance tendinopathies. Each of these subsets of Achilles tendon injuries presents 
their own outcomes, affectations, and complicated treatment strategies. No single 
treatment has been established as the best option for clinicians faced with any of the 
myriad calcaneal tendon injuries, and further study of these treatments is needed. Each of 
the various Achilles tendon injuries are disruptive to the normal functioning of the 
tendon, disrupting the biomechanical effectiveness of the tissue. The Achilles tendon 
itself serves a very particular biomechanical role facilitated by the unique properties of 
the tissue. The cellular and extracellular components of the Achilles tendon, their 
characteristics, and their strict organization gives rise to these important biomechanical 
properties. The homeostasis of these tissue components is a complex and highly regulated 
process involving a number of molecules and cells. Disruptions in any of these 
interconnected systems can lead directly or indirectly to disorganization of the highly 
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organized and balanced network of cells and extracellular substances that make up the 
Achilles tendon. This dysregulation provides a probable explanation for the varying risks 
of Achilles tendon injuries, and an important area for further research. All of these 
concepts, taken together, provide an understanding of the etiology, mechanisms, and 
treatments of Achilles tendon injury, painting a picture of an increasingly common and 
damaging injury worthy of further study.                                                       
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